Orchid Pharma Q3 FY24 Results
Orchid Pharma has released its financial results for the Q3 quarter of Financial Year 23-2024. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 220.59 Cr
- Quarter-on-Quarter (QoQ) Change: 10.99% (Previous Quarter: Rs. 198.76 Cr )
- Year-on-Year (YoY) Change: 38.08% (Same Quarter Last Year: Rs. 159.76 Cr )
Profitability Metrics
- Net Profit: Rs. 29.43 Cr
- QoQ Profit Change: 48.62% (Previous Quarter: Rs. 19.80 Cr )
- YoY Profit Change: 287.92% (Same Quarter Last Year: Rs. 7.59 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 6.18
- QoQ EPS Change: 43.72% (Previous Quarter: Rs. 4.30)
- YoY EPS Change: 232.26% (Same Quarter Last Year: Rs. 1.86)
Performance Summary
Exceptional
Orchid Pharma showed amazing growth in profits, beating even the strong sales increase. This means the company is making more money from each sale.
This analysis provides a snapshot of Orchid Pharma's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.